filings.toolsItem 6. Selected Financial Data.
4K characters. Original on sec.gov · Markdown
Item 6. Selected Financial Data.
The selected consolidated financial data of CVS Health Corporation as of and for the periods indicated in the five-year period ended December 31, 2019, has been derived from the consolidated financial statements of CVS Health Corporation. The selected consolidated financial data should be read in conjunction with the MD&A included in Item 7 of this 10-K and the audited consolidated financial statements and related notes included in Item 8 of this 10-K.
| In millions, except per share amounts | 2019 | 2018 (1) | 2017 | 2016 | 2015 | ||||||||||||||
| Statement of operations data: | |||||||||||||||||||
| Total revenues | $ | 256,776 | $ | 194,579 | $ | 184,786 | $ | 177,546 | $ | 153,311 | |||||||||
| Operating income | 11,987 | 4,021 | 9,538 | 10,386 | 9,496 | ||||||||||||||
| Income (loss) from continuing operations | 6,631 | (596 | ) | 6,631 | 5,320 | 5,230 | |||||||||||||
| Net income (loss) attributable to CVS Health | 6,634 | (594 | ) | 6,622 | 5,317 | 5,237 | |||||||||||||
| Per common share data: | |||||||||||||||||||
| Basic earnings (loss) per common share: | |||||||||||||||||||
| Income (loss) from continuing operations attributable to CVS Health | $ | 5.10 | $ | (0.57 | ) | $ | 6.48 | $ | 4.93 | $ | 4.65 | ||||||||
| Income (loss) from discontinued operations attributable to CVS Health | $ | — | $ | — | $ | (0.01 | ) | $ | — | $ | 0.01 | ||||||||
| Net income (loss) attributable to CVS Health | $ | 5.10 | $ | (0.57 | ) | $ | 6.47 | $ | 4.93 | $ | 4.66 | ||||||||
| Diluted earnings (loss) per common share: | |||||||||||||||||||
| Income (loss) from continuing operations attributable to CVS Health | $ | 5.08 | $ | (0.57 | ) | $ | 6.45 | $ | 4.91 | $ | 4.62 | ||||||||
| Income (loss) from discontinued operations attributable to CVS Health | $ | — | $ | — | $ | (0.01 | ) | $ | — | $ | 0.01 | ||||||||
| Net income (loss) attributable to CVS Health | $ | 5.08 | $ | (0.57 | ) | $ | 6.44 | $ | 4.90 | $ | 4.63 | ||||||||
| Dividends per common share | $ | 2.00 | $ | 2.00 | $ | 2.00 | $ | 1.70 | $ | 1.40 | |||||||||
| Balance sheet and other data: | |||||||||||||||||||
| Total assets | $ | 222,449 | $ | 196,456 | $ | 95,131 | $ | 94,462 | $ | 92,437 | |||||||||
| Long-term debt, less current portion | $ | 64,699 | $ | 71,444 | $ | 22,181 | $ | 25,615 | $ | 26,267 | |||||||||
| Total shareholders’ equity | $ | 64,170 | $ | 58,543 | $ | 37,695 | $ | 36,834 | $ | 37,203 | |||||||||
| Number of stores (at end of year) | 9,941 | 9,967 | 9,846 | 9,750 | 9,681 |
| (1) | On November 28, 2018, the Company acquired Aetna. Aetna’s operations are included in the Company’s consolidated financial statements subsequent to the Aetna Acquisition Date. See Note 2 ‘‘Acquisitions and Divestitures’’ included in Item 8 of this 10-K for additional information. |
Previous: Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. · Next: Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations. (“MD&A”)
Sponsor Sponsor this sector. One slot per industry, shown on every filing in it. Details